VTGN: Vistagen Therapeutics Company Short-Term Debt
Vistagen Therapeutics is developing fast-acting anti-anxiety medications in collaboration with specialized institutes. Total short-term debt is moving steadily, while 0.00 shows the current volume of this metric. However, high R&D expenses are weighing on profits, and global political instability and patent risks are creating barriers to the international registration of new drugs.
Metric breakdowns and analytics for VistaGen Therapeutics, Inc. (VTGN)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Vistagen Therapeutics|VTGN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio VistaGen Therapeutics Inc|VTGN - Company Cumulative Indebtedness|Debts to Book Capitalization Vistagen Therapeutics|VTGN - Company Long-Term Debts|Company Short-Term Debts Vistagen|Quick Ratio vistagen.com
- earnings and valuation multiples indicators:
Summary company analytics:vistagen.com (VTGN)
Investors expect strict liquidity control from the biopharmaceutical sector, particularly when a company develops a closed ecosystem of nasal sprays for the treatment of neuropsychiatric disorders. When analyzing the short-term debt profile, one must evaluate the issuer's ability to meet obligations within a year, which confirms the financial stability of Vistagen Therapeutics (VTGN) and the absence of sudden default risks during the implementation of its innovative portfolio.
Competitors of Vistagen Therapeutics (VTGN)
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Current Liabilities ACAD|Company Short-Term Debt XENE|Company Short-Term Debts VKTX|Short-Term Debt Volume Supernus Pharmaceuticals, Inc.|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|Short-Term Debt Volume Denali Corp (DNLI)|HRMY: Company Current Liabilities|biohavenpharma.com - Amount of Current Liabilities|AMLX: Company Short-Term Debts|Trevi Therapeutics Inc (TRVI) - Company Short-Term Debts|PRAX (Praxis Medicines) - Company Short-Term Debts|AVXL - Short-Term Indebtedness|Company Short-Term Debts CBLL|PRTA - Short-Term Debt|Company Short-Term Debt Alector ALEC|ANNX: Company Short-Term Indebtedness|OMER: Company Current Liabilities|Company Short-Term Loans and Borrowings NGNE (Neurogene Therapeutics)|ACIU (AC Immune) - Company Current Liabilities|VYGR: Amount of Current Liabilities|NMRA (Neumora Therapeutics, Inc.) - Company Short-Term Debts|SCLX: Company Short-Term Loans and Borrowings|Company Short-Term Debts TVGN|ACOG - Short-Term Debt|Company Short-Term Debt Cognition Therapeutics, Inc. CGTX|Company Short-Term Loans and Borrowings IKT|Cassava Sciences - Company Short-Term Debts|ASRT - Company Short-Term Debts|coyatherapeutics.com (COYA) - Company Short-Term Debt|Current Liabilities OVID (Ovid Therapeutics)|ABOS (Acumen Pharmaceuticals) - Company Short-Term Debts|Short-Term Debt cervomed.com CRVO|Company Current Liabilities ATHE (Alterity Therapeutics)|Company Short-Term Debts clene.com (CLNN)|PepGen - Company Current Liabilities|Amount of Current Liabilities JUNS (jupiterneurosciences.com)|Relmada Therapeutics - Company Short-Term Debts|Short-Term Debt Volume annovisbio.com ANVS|GRCE: Company Short-Term Debts|Company Current Liabilities Firefly Neuroscience, Inc.|Company Short-Term Debt ANEW Medical|NeuroSense Therapeutics, Ltd. (NRSN) - Short-Term Debt Volume|Company Current Liabilities RVPH (Reviva Pharmaceuticals)|Company Short-Term Debt MTVA (metaviatx.com)|NeurAxis - Company Current Liabilities|Amount of Current Liabilities HSDT (Helius Medical Technologies, Inc.)|Passage Bio Corp - Company Short-Term Debts|Short-Term Indebtedness Neuphoria Therapeutics Inc. (NEUP)|Minerva Neurosciences (NERV) - Company Short-Term Debt|Company Short-Term Indebtedness ATHA|Company Short-Term Debt Addex Therapeutics Ltd|Company Short-Term Indebtedness ALZN (Alzamend)|Company Short-Term Debts CYCN|PTIX - Short-Term Debt|Pasithea Therapeutics Corp. - Company Current Liabilities|Company Short-Term Debts Cortigent Inc CRGT|ATXI - Company Short-Term Debt|Company Short-Term Loans and Borrowings BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|Short-Term Debt Chromocell (CHRO)|Company Current Liabilities ELYM|Company Short-Term Debt ITCI|Company Short-Term Debts LBPH|Short-Term Debt Volume Marinus Pharmaceuticals Inc|Company Short-Term Debt NKGen NKGN|Short-Term Debt Volume NeuroBo Pharma (NRBO)|SAGE: Company Current Liabilities|synaptogen.com - Amount of Current Liabilities|TRVN: Company Short-Term Debts|Vigil Neuroscience, Inc. (VIGL) - Company Short-Term Debts|WENA (Anew Medical, Inc.) - Company Short-Term Debts|CERE - Short-Term Indebtedness